161 related articles for article (PubMed ID: 14502256)
1. Severe liver disease is caused by HBV rather than HCV in children with hematological malignancies.
El-Sayed MH; Mohamed MM; Karim A; Maina AM; Oliveri F; Brunetto MR; Bonino F
Hematol J; 2003; 4(5):321-7. PubMed ID: 14502256
[TBL] [Abstract][Full Text] [Related]
2. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.
Kawatani T; Suou T; Tajima F; Ishiga K; Omura H; Endo A; Ohmura H; Ikuta Y; Idobe Y; Kawasaki H
Eur J Haematol; 2001 Jul; 67(1):45-50. PubMed ID: 11553266
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
[TBL] [Abstract][Full Text] [Related]
4. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
Faggioli P; De Paschale M; Tocci A; Luoni M; Fava S; De Paoli A; Tosi A; Cassi E
Haematologica; 1997; 82(1):38-42. PubMed ID: 9107080
[TBL] [Abstract][Full Text] [Related]
5. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
Abruzzi A; Fried B; Alikhan SB
Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
[TBL] [Abstract][Full Text] [Related]
6. Major risk of blood transfusion in hemolytic anemia patients.
Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
[TBL] [Abstract][Full Text] [Related]
7. Lamivudine facilitates optimal chemotherapy in hepatitis B virus-infected children with hematological malignancies: a preliminary report.
el-Sayed MH; Shanab G; Karim AM; el-Tawil A; Black A; Dixon JS
Pediatr Hematol Oncol; 2004 Mar; 21(2):145-56. PubMed ID: 15160513
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy.
Takai S; Tsurumi H; Ando K; Kasahara S; Sawada M; Yamada T; Hara T; Fukuno K; Takahashi T; Oyama M; Onishi H; Tomita E; Takami T; Imawari M; Moriwaki H
Eur J Haematol; 2005 Feb; 74(2):158-65. PubMed ID: 15654908
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia.
Abe K; Hayakawa E; Sminov AV; Rossina AL; Ding X; Huy TT; Sata T; Uchaikin VF
J Clin Virol; 2004 May; 30(1):57-61. PubMed ID: 15072755
[TBL] [Abstract][Full Text] [Related]
10. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
Tanaka T; Inoue K; Hayashi Y; Abe A; Tsukiyama-Kohara K; Nuriya H; Aoki Y; Kawaguchi R; Kubota K; Yoshiba M; Koike M; Tanaka S; Kohara M
J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of chronic hepatitis in children with cancer.
Sevinir B; Meral A; Günay U; Ozkan T; Ozuysal S; Sinirtas M
Med Pediatr Oncol; 2003 Feb; 40(2):104-10. PubMed ID: 12461794
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
[TBL] [Abstract][Full Text] [Related]
14. Influence of hepatitis B and hepatitis C virus infection on the outcome of kidney transplantation.
Yuan CH; Liu YF; Li GC
Chin Med Sci J; 2005 Jun; 20(2):129-32. PubMed ID: 16075755
[TBL] [Abstract][Full Text] [Related]
15. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma.
Pramoolsinsap C; Sumalnop K; Busagorn N; Kurathong S
Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):6-11. PubMed ID: 1326124
[TBL] [Abstract][Full Text] [Related]
17. Dual or single hepatitis B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment.
Utili R; Zampino R; Bellopede P; Marracino M; Ragone E; Adinolfi LE; Ruggiero G; Capasso M; Indolfi P; Casale F; Martini A; Di Tullio MT
Blood; 1999 Dec; 94(12):4046-52. PubMed ID: 10590048
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
19. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and presentation of hepatitis C related chronic liver disease in southern India.
Issar SK; Ramakrishna BS; Ramakrishna B; Christopher S; Samuel BU; John TJ
J Trop Med Hyg; 1995 Jun; 98(3):161-5. PubMed ID: 7783272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
